The number of adults in the UK being treated for gender dysphoria in the NHS has risen by 75 per cent in five years, MailOnline could reveal.
The latest figures from 2021 show that more than 11,000 patients have received care for a condition that makes victims feel they have been born the wrong sex.
This is 74 percent more than the 6,371 patients being treated in 2016.
Diagnosis of penile dysphoria is the first step in receiving cross-sex hormone therapies that help trans people develop their favorite sex characteristics.
It comes amid a nationwide shortage of hormone replacement therapy that is also used to reduce the symptoms of mesopause.
In 2021 approximately 1,600 trans patients were prescribed the female hormone estrogen, the most popular HRT drug with the lowest in stock.
However, data is only available for four out of 12 gender clinics that provide information to MailOnline, so the total number is believed to be higher.
The current lack of HRT has forced menopausal women to trade rations, trade supplies in car parks or return to the black market.
This map shows the geographical distribution of gender dysphoria patients in the UK from NHS clinics providing data to MailOnline.
MailOnline tracked data on gender dysphoria based on Freedom of Information (FOI) requests sent to 12 NHS gender clinics in the UK.
Of these, 11 provided data on their sick numbers spread in 2016, or when they first opened.
Only four of the services were able to provide the number of patients prescribed estrogen as part of their treatment, which means the overall probability is high.
A total of 11,085 gender dysphoria patients were treated in 2021/22 compared to 6,371 in 2016/17.
Of the 2021 patients, 1,592 were prescribed estrogen.
For men who are known to be feminine, estrogen helps to reduce testicles, reduce facial hair and muscles, and leads to the development of breast tissue and rounded hips.
In women going through menopause, HRT replaces the hormones that the body stops making during menopause.
It is used to treat debilitating symptoms such as hot flashes, cerebral palsy, joint pain, mood swings and vaginal dryness.
An estimated one million British women are taking some form of HRT for their menopausal symptoms, with NHS data showing prescriptions for these drugs reaching more than 500,000 in February alone.
The current HRT crisis has stopped desperate women from getting rations, black-marketing or smuggling drugs into the UK from abroad.
The number of these patients is determined by estrogen, which helps people with the condition to become more feminine. The data was provided by only four gender clinics in the country
‘Ideological’ outrage over new NHS trans pregnancy advice that refers to ‘breast-feeding’
The new NHS advice for trans parents has been described as “ideological” for failing to mention the word “breast” and for “generalizing” potentially dangerous breast-binding techniques.
The guidelines encourage people to continue taking hormone-transmitting drugs while breastfeeding. It is not clear what effect this may have on your baby.
The advice was written a year ago but was released online this week after nearly a year of internal strife over whether to publish it.
This has raised concerns among nurses and members of the public, who say the advice failed to warn people about health risks for both parents and children.
The page titled ‘Chestfeeding if you are trans or non-binary’ makes no mention of breasts and refers to breast reduction operations as ‘top surgery’.
The advice also includes a binding section, a technique used by women to flatten men’s breasts, usually with extremely tight fitting bras.
Experts have warned that the technology could lead to rib fractures, fractures, difficulty breathing and infection.
In 2008 NHS England advised that bindings should only be used for a short period of time as it could cause ‘back problems’ and distort the breast tissue. Which could affect any future breast removal surgery.
The Nottinghamshire Healthcare NHS Foundation Trust is responsible for the lion’s share of gender dysphoria patients in the UK, our analysis shows.
The trust’s Nottingham Center for Transgender Health treated 5,050 patients in 2021 – about half of that year’s total.
In second place was The Welsh Gender Service, which launched in 2019 alone and recorded 1,679 patients in fiscal year 2021.
This is double the number of patients treated in the previous year and eight times more than the first year of surgery.
Third place for 2021 was the Gender Dysphoria Clinic of the Northamptonshire Healthcare NHS Foundation Trust.
It treated 1,475 patients last year, almost double the number in 2016.
For Scotland, Sandiford, run by the NHS Greater Glasgow and Clyde, had the highest number of sick clinics, at 742 in 2021, down from eight in 2016.
The Northern Ireland Gender Dysphoria Service, operated by the Belfast Health and Social Care Trust’s Brackenburn Clinic, recorded 58 cases in 2021 alone.
Of the 12 NHS trusts, only four provided data on the number of patients given estrogen in 2021.
These were Chelsea and Westminster Hospitals, NHS Highland in Scotland, Sheffield Health and Social Care, and Northamptonshire Healthcare.
Northamptonshire Healthcare had the highest number of estrogen patients in 2021, at 1,341.
About 91 percent of people treated for gender dysphoria that year.
It was followed by Chelsea and Westminster Hospital with 201 patients, about 55 per cent of its total patients, and NHS Highland, which treated between 40 and 50 patients with estrogen.
NHS Highland told MailOnline how it was able to provide accurate data on how various HRT drugs were listed in its database and how Covid changed prescription rules in 2021.
Sheffield Health and Social Care provided estrogen to 38 patients in 2021, about 12 percent of its total patient population.
Data collected by MailOnline shows only adults treated for gender dysphoria.
Children with this condition are treated at the Tavistock and Portman NHS Foundation Trust through the Gender Identification Development Service (GIDS) which has two main clinics, one in London and one in Leeds.
GIDS has seen a dramatic increase in its annual caseload over the past decade. In 2010/11, only 138 children were referred for treatment. But it has increased 17 times to 2,383 in 2020/21.
There are also currently 5,500 children on the NHS’s waiting list for sex exchange treatment as demand increases following the lockdown.
HRT is not usually given to children with gender dysphoria, but puberty can be stopped after counseling at various stages.
If they are 16 years old and have been on hormone blockers for at least a year, they can be given HRT.
Around 512,000 NHS prescriptions were written in England for ‘female sex hormones and their modulators’ in February, the latest official figures show, compared to 265,000 in March 2017. Most of these will be HRT drugs but some may include other female hormone drugs. As a contraceptive
60p ‘Sex Transformation’ pills are being sold on eBay
Sex change pills claiming to make users ‘Grow Boobs’ are being sold on eBay, MailOnline may reveal.
The online marketplace has dozens of lists for ‘feminisar’ and ‘masculine-transitioning’ tablets, which can be purchased as a 60p grinder.
They are marketed using sellers of the most popular products in London, Bristol and Newcastle, using either volunteer women or muscle-tied men.
Many of the items seen by MailOnline made suspicious health claims, which doctors warned were designed to prey on depressed patients with penile dysphoria.
One of the targets for trans women said that a daily dose helps them to develop ‘breast augmentation’, ‘pert and feminine bottoms’ and make their voice ‘loud and feminine’.
Another marketed among trans men claimed to be able to ‘increase facial hair’, ‘increase strength and muscle mass’ and ‘reduce breasts’.
Some products have been purchased hundreds of times, although there is no evidence that any of the listed ingredients will cause the desired effect.
Doctors told MailOnline that they are snake oil supplements that do nothing but, worst of all, contain body-warping hormones.
Waiting times for gender identity clinics have increased significantly in recent years as the condition has become more widely accepted.
Some clinics, such as the Nottingham Center for Transgender Health, are now contacting patients who were originally referred in February 2020.
The Nottinghamshire Healthcare NHS Foundation Trust has a 49-month waiting list.
There are currently five Ostrogon drugs in the UK that are severely under-supplied.
These are different doses of Oestrogel, Ovestin, Premique, Lenzetto and Sandrena.
There has been a huge increase in women seeking HRT by issuing an estimated 538,000 prescriptions in December, compared to 238,000 in January 2017.
The prescription for Oestrogel, which is used by around 30,000 in the UK, has also increased dramatically.
Some gender dysphoria clinics have warned their patients about osteogel deficiency and advised users to replace their normal functions with alternative medications such as Lenzeto and Sandrena.
It is not known how many trans people will be affected by estrogen deficiency.
If the transwoman, a male-to-female person, stops taking HRT male features such as facial hair can return which can trigger or increase the feeling of penile dysphoria.
Health Minister Sajid Javid has vowed to take action on the UK’s HRT crisis.
Last month, she hired new HRT Czar Madeleine McTernan with a mission to secure menopausal drugs from over-supplied countries in Europe and North America.
About two weeks ago the government also issued a Critical Reduction Protocol (SSP), enabling authorities to hand over alternative forms of HRT to pharmacists so that patients do not have to return to their GP for a new prescription.
But pharmacists warn that, despite official assurances, local regulations still prevent GPs from recommending brands of HRT that many women want.
There are no accurate estimates of how many trans people there are in the UK, but the government estimates there are between 200,000-500,000.
Source: | This article is originally from Dailymail.co.uk